Results 141 to 150 of about 1,364 (160)
Some of the next articles are maybe not open access.
Droxidopa for Intravenous Vasopressor Weaning in the Intensive Care Unit: A Descriptive Study
TherapeuticsBackground/Objectives: Our objective was to describe the safety and efficacy of enteral droxidopa, a norepinephrine prodrug, for intravenous (IV) vasopressor weaning in intensive care unit (ICU) patients.
Calvin Diep +2 more
semanticscholar +1 more source
Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension.
Parkinsonism & Related Disorders, 2022L. Marsili +7 more
semanticscholar +1 more source
Droxidopa management by an integrated health-system specialty pharmacy team.
Journal of the American Pharmacists Association, 2022Sabrina Livezey +6 more
semanticscholar +1 more source
Journal of the American Society of Nephrology, 2022
Lakshna Sankar, Kartik Kalra
semanticscholar +1 more source
Lakshna Sankar, Kartik Kalra
semanticscholar +1 more source

